You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 2, 2025

Details for Patent: 7,696,236


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,696,236 protect, and when does it expire?

Patent 7,696,236 protects ESBRIET and is included in one NDA.

This patent has twenty-one patent family members in fourteen countries.

Summary for Patent: 7,696,236
Title:Method of providing pirfenidone therapy to a patient
Abstract: The invention relates to methods for decreasing adverse events associated with pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone) therapy. The invention discloses an optimized dose escalation scheme that results in the patient having increased tolerance to adverse events associated with the administration of pirfenidone. The invention also discloses a starter pack that may be used in conjunction with the dose escalation scheme.
Inventor(s): Bradford; Williamson Z. (Ross, CA)
Assignee: InterMune, Inc. (Brisbane, CA)
Application Number:12/427,532
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,696,236
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,696,236: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope and claims is crucial for determining its validity, enforceability, and potential impact on the market. This article will delve into the specifics of United States Patent 7,696,236, exploring its claims, scope, and the broader patent landscape.

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and what is protected by the patent. The claims must be clear, concise, and supported by the description in the patent specification[3].

Patent 7,696,236 Overview

To analyze the scope and claims of United States Patent 7,696,236, one must first identify the patent's title, inventors, and the assignee. Here is a general outline:

  • Title: The title provides a brief description of the invention.
  • Inventors: The individuals who created the invention.
  • Assignee: The entity that owns the patent.

Reading the Patent Document

The patent document is divided into several sections, including the abstract, background of the invention, summary of the invention, detailed description of the invention, and the claims.

Abstract

The abstract provides a concise summary of the invention, highlighting its key features and purpose.

Background of the Invention

This section explains the context and prior art related to the invention, helping to understand the problem the invention solves.

Summary of the Invention

A brief overview of the invention, including its main components and how it works.

Detailed Description of the Invention

This section provides a detailed explanation of the invention, including drawings and diagrams. It is essential for understanding the scope of the invention.

Claims

The claims section is the most critical part of the patent document. Here, you will find the independent and dependent claims that define what is protected by the patent.

Analyzing the Claims

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are typically broader and more general than dependent claims[3].

Dependent Claims

Dependent claims refer back to an independent claim and add additional limitations. They are narrower and more specific.

Scope of the Patent

The scope of a patent is determined by its claims. Here are some key metrics to consider:

  • Independent Claim Length and Count: Research suggests that the length and number of independent claims can be metrics for measuring patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

  • Forward Citations: The number of forward citations (citations received by the patent) can indicate the patent's impact and relevance in the field.

  • Breadth of Patent Classes: The number of patent classes under which the patent is classified can indicate its breadth and applicability across different areas.

Patent Landscape

Understanding the broader patent landscape is crucial for assessing the significance and potential challenges of a patent.

Prior Art

Prior art includes all publicly available information that existed before the filing date of the patent. Searching prior art is essential to ensure the novelty and non-obviousness of the invention[1].

Global Dossier

The Global Dossier service allows users to see the patent family for a specific application, including related applications filed at participating IP Offices. This can help in understanding the global reach and related filings of the patent[1].

International Patent Offices

Checking databases from other international intellectual property offices, such as the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can provide insights into whether similar inventions have been patented abroad[1].

Practical Steps for Analysis

Using Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching existing patents and published patent applications. It provides enhanced access to prior art and can help in analyzing the scope and claims of a patent[1].

Consulting Patent and Trademark Resource Centers (PTRCs)

Local PTRCs offer training in patent search techniques and maintain local search resources, which can be invaluable for a detailed analysis[1].

Reviewing Office Actions

The Patent Examination Data System (PEDS) and the Global Dossier service provide access to office actions and file histories, which can offer insights into the examination process and any challenges the patent faced[1].

Legal and Litigation Aspects

Patents can be involved in litigation, and understanding the legal landscape is crucial.

Patent Infringement

If a patent is alleged to infringe on another patent, it can lead to legal disputes. For example, a company might file a patent infringement lawsuit against another entity using the patented technology without permission[4].

Licensing Agreements

Patents can be licensed to other companies, which can impact their scope and enforcement. Licensing agreements can provide revenue streams and expand the use of the patented technology[4].

Key Takeaways

  • Claims Analysis: The claims section of a patent is critical for understanding what is protected.
  • Scope Metrics: Independent claim length and count, forward citations, and breadth of patent classes are important metrics.
  • Global Landscape: Checking international databases and using services like Global Dossier can provide a comprehensive view.
  • Legal Considerations: Understanding office actions, litigation risks, and licensing agreements is essential.

FAQs

  1. What is the importance of independent claims in a patent? Independent claims define the invention without reference to other claims and are typically broader and more general than dependent claims.

  2. How can I determine the scope of a patent? The scope can be determined by analyzing the claims, particularly independent claims, and metrics such as independent claim length and count, forward citations, and the breadth of patent classes.

  3. What is the Global Dossier service? The Global Dossier service provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family for a specific application.

  4. Why is prior art important in patent analysis? Prior art ensures the novelty and non-obviousness of the invention by comparing it to all publicly available information that existed before the filing date.

  5. How can I search for patents internationally? You can use databases from international intellectual property offices such as the EPO, JPO, and WIPO, and services like PATENTSCOPE provided by WIPO.

Sources

  1. USPTO - Search for patents https://www.uspto.gov/patents/search
  2. US Courts - Report on Filing Patent/Trademark https://www.uscourts.gov/forms-rules/forms/report-filing-patent-trademark
  3. SSRN - Patent Claims and Patent Scope https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Annual Reports - Identification and Verification Systems https://www.annualreports.com/HostedData/AnnualReportArchive/i/AMEX_IDN_2003.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,696,236

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genentech Inc ESBRIET pirfenidone CAPSULE;ORAL 022535-001 Oct 15, 2014 AB RX Yes Yes 7,696,236 ⤷  Subscribe DOSE ESCALATION OVER 14 DAYS FOR TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,696,236

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria E506060 ⤷  Subscribe
Canada 2667654 ⤷  Subscribe
Cyprus 1111699 ⤷  Subscribe
Germany 602007014113 ⤷  Subscribe
Denmark 2124945 ⤷  Subscribe
European Patent Office 2124945 ⤷  Subscribe
European Patent Office 2338489 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.